2020 ASCO Virtual Direct™ Highlights

 

Lung
13:52

2020 ASCO Virtual Direct™ Highlights

Targeting Exon 20 Insertions in NSCLC: Anti-Tumor Activity With T-Dxd in HER2m Disease, Assessing Efficacy of Treatment Options in EGFRm Disease

FEATURING Ibiayi Dagogo-Jack
  • 318 views
  • January 28, 2021
  • 3
18:53

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on 1L Treatment of ES-SCLC: IO + Chemo - Results from KEYNOTE-064 Study (Pembro + EP Improve PFS) & CASPIAN Study (Durvalumab + EP new SoC)

FEATURING Nagashree Seetharamu
  • 249 views
  • July 10, 2020
10:35

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on NSCLC: Neoadjuvant Chemo for Locally Advanced Disease, Gefitinib vs Chemo for EGFR+ NSCLC & Adjuvant Osimertinib ‘Practice Changing’ for Early-Stage EGFR Mutated NSCLC

FEATURING Nagashree Seetharamu
  • 89 views
  • July 15, 2020
22:55

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on 1st Line IO Strategies for Metastatic NSCLC: Should CheckMate 227 (Ipi + Nivo) and CheckMate 9LA (Nivo/Ipi + Chemo) Data Change My Practice? Tiragolumab/Atezolizumab Shows Promising Activity in PD-L1+ NSCLC

FEATURING Ibiayi Dagogo-Jack
  • 734 views
  • July 13, 2020
  • 1